Upgrading for Safety: $1.2M Project to Replace Asbestos-Infused Water Pipes in North Huntingdon A $1.2 million infrastructure upgrade is underway in North Huntingdon to replace nearly a mile of aging waterline—some of which contains asbestos-infused cement pipes dating back to the early 1950s. Approved by the Municipal Authority of Westmoreland County (MAWC), the project aims […]
Pennsylvania Supreme Court Ruling Opens Door to Mesothelioma Claims Against Employers Beyond Statutory Limits
Pennsylvania Supreme Court Ruling Opens Door to Mesothelioma Claims Against Employers Beyond Statutory Limits In a major victory for asbestos victims and their families, the Pennsylvania Supreme Court recently issued a powerful 5-2 opinion affirming the right of workers suffering from long-latency occupational diseases—such as mesothelioma—to pursue legal action against their employers even after the […]
Homer City Power Station Demolished
Homer City Power Station Demolished On March 22, 2025, the smokestacks and cooling towers of the Homer City Power Station in Indiana County came crashing down in a planned implosion. The demolition marked the physical end of the coal-fired power plant, which had ceased operations in 2023 due to economic pressures and shifting energy trends. […]
U-Haul Fined for Asbestos Exposure Violations
U-Haul Fined for Asbestos Exposure Violations U-Haul is facing a financial penalty after an investigation revealed that mechanics working at its facility were unknowingly exposed to hazardous asbestos-containing materials. The Washington State Department of Labor & Industries (L&I) conducted an in-depth inquiry and subsequently issued a $231,000 fine against the company, citing multiple violations related […]
National Cancer Prevention Month 2025
National Cancer Prevention Month 2025 February is National Cancer Prevention Month. Cancer prevention is the action taken to lower the risk of getting cancer. There are multiple ways to reduce the risk of getting cancer including maintaining a healthy lifestyle, avoiding cancer causing substances, and taking medicines or vaccines that prevent cancer from developing. The […]
Risks of Asbestos Exposure due to Los Angeles Wildfires
Risks of Asbestos Exposure due to Los Angeles Wildfires Thousands of people are under mandatory evacuation as wildfires rampage the Los Angeles area of Southern California. Other people are making the decision to leave their homes and businesses as the fires spread rapidly. A state of emergency was declared for the area. As the flames […]
Understanding the FDA’s Proposed Asbestos Testing Rule for Talc-Containing Products
Understanding the FDA’s Proposed Asbestos Testing Rule for Talc-Containing Products The U.S. Food and Drug Administration (FDA) has recently proposed a new rule aimed at protecting consumers from potential asbestos contamination in talc-containing cosmetic products. This initiative comes in response to growing concerns over the risks associated with asbestos exposure and its link to various […]
EPA Advances Efforts to Address Asbestos Risks with Comprehensive Evaluation of Legacy Uses
EPA Advances Efforts to Address Asbestos Risks with Comprehensive Evaluation of Legacy Uses The Environmental Protection Agency (EPA) has taken a significant step toward reducing the dangers posed by asbestos with the release of its final Risk Evaluation for Asbestos. This evaluation delves into the risks associated with legacy uses and the disposal of asbestos, […]
Revolutionizing Mesothelioma Detection: Mayo Clinic’s New Blood Test
Revolutionizing Mesothelioma Detection: Mayo Clinic’s New Blood Test Mesothelioma, a rare and aggressive cancer caused by asbestos exposure, poses significant challenges when it comes to early detection. Each year, approximately 3,000 new cases are diagnosed in the United States, with many patients only learning of their condition when treatment options are limited. To address this, […]
Keytruda’s New FDA Approval for Mesothelioma: A Breakthrough in Treatment
Keytruda’s New FDA Approval for Mesothelioma: A Breakthrough in Treatment The U.S. Food and Drug Administration (FDA) has recently expanded the use of Keytruda (pembrolizumab), an immunotherapy drug, marking a significant advancement in the treatment of unresectable advanced or metastatic malignant pleural mesothelioma (MPM). Approved on September 17, 2024, the combination of Keytruda with pemetrexed […]